-
The pharmaceutical company expects to double the number of R&D teams by 2023
Time of Update: 2023-01-05
TF Securities recently said in a research report on Bede Pharmaceutical that the company focuses on the business of drug molecular building blocks and scientific reagents, with outstanding variety richness and quality/price advantages, and the penetration rate of downstream new drug R&D customers has gradually increased; Forward-looking strategic layout in the international market, global multi-center layout in the United States, India, Germany and other places, rich customer resources at home and abroad.
-
New research overturns old ideas about how hearing works
Time of Update: 2022-12-30
Anders Fridberger, a professor in the Department of Biomedical and Clinical Sciences, said: "We think this makes it easier for people to experience low-frequency sounds because the brain receives information from many sensory cells at the same time.
-
Handover on August 30th
Time of Update: 2022-10-12
Complete set of technologies It is understood that the 50,000-ton/year propane dehydrogenation project is a non-metal environmental-friendly fluidized bed catalytic dehydrogenation of propane to propylene with independent intellectual property rights developed by China University of Petroleum (East China) and East China Design Institute after nearly ten years of research and development.
-
Notice of the Second AI Drug Research and Development Conference
Time of Update: 2022-08-30
, Ltd. Chief Scientific Officer of Alma Bio, Zhao Yu, Deputy Director of Turing Darwin Laboratory, Institute of Computing Technology, Chinese Academy of Sciences; Co-founder of Zheyuan Technology Support Media Contact us hezhengshen@shengjiejituan.
-
BeiGene Announces Updated Results of RATIONALE-309, Phase 3 Clinical Trial of BeiGene(R) in First-Line Recurrent or Metastatic Nasopharyngeal Carcinoma at ASCO Plenary Session Series
Time of Update: 2022-05-20
5 monthsThe trial's secondary endpoint results were consistent with the interim analysisBEIJING, China, CAMBRIDGE, MA, USA and BASEL, Switzerland, April 19, 2022 /PRNewswire/ -- BeiGene (NASDAQ: BGNE; HK: 06160; S: 688235) is A global science-based biotechnology company focused on developing innovative, affordable medicines designed to improve outcomes and improve access to medicines for patients around the world .
-
Wuhan will build a special hospital in accordance with the "Xiaotangshan" model by February 3
Time of Update: 2020-01-24
Novel coronavirus pneumonia was reported on the evening of 23 July The Wuhan municipal government will build a special hospital in accordance with the Beijing Xiao Tang Shan Hospital mode to enhance t
-
Knowledge of check valve: introduction of duck shaped flexible check valve
Time of Update: 2009-06-08
Duck billed flexible check valve is mainly used in water-proof system, discharge system, water pump outlet, lifting pump station and submerged aeration system The main features of duck billed flexible
